95 related articles for article (PubMed ID: 1775269)
1. Suppression of beta 2-microglobulin release from lymphocytes by dialysis membranes.
Schaefer RM; Paczek L; Heidland A
Nephrol Dial Transplant; 1991; 6 Suppl 3():53-6. PubMed ID: 1775269
[TBL] [Abstract][Full Text] [Related]
2. Dialysis membranes inhibit in vitro release of beta-2-microglobulin from human lymphocytes.
Paczek L; Schaefer RM; Heidland A
Nephron; 1990; 56(3):267-70. PubMed ID: 2077409
[TBL] [Abstract][Full Text] [Related]
3. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
Zingraff J; Beyne P; Ureña P; Uzan M; Nguyen Khoa Man ; Descamps-Latscha B; Drüeke T
Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
[TBL] [Abstract][Full Text] [Related]
4. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
5. Dialysis membranes decrease immunoglobulin and interleukin-6 production by peripheral blood mononuclear cells in vitro.
Paczek L; Schaefer RM; Heidland A
Nephrol Dial Transplant; 1991; 6 Suppl 3():41-4. PubMed ID: 1775266
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients.
Ferreira A; Ureña P; Ang KS; Simon P; Morieux C; Souberbielle JC; de Vernejoul MC; Drüeke TB
Nephrol Dial Transplant; 1995; 10(9):1701-7. PubMed ID: 8559492
[TBL] [Abstract][Full Text] [Related]
7. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
8. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?
Tielemans C; Dratwa M; Bergmann P; Goldman M; Flamion B; Collart F; Wens R
Nephrol Dial Transplant; 1988; 3(3):291-4. PubMed ID: 3140103
[TBL] [Abstract][Full Text] [Related]
9. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
Baldrati L; Baldrati L; Delvecchio C; Capponcini C; Docci D; Turci F; Feletti C
Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
[TBL] [Abstract][Full Text] [Related]
10. Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility.
Bommer J; Seelig P; Seelig R; Geerlings W; Bommer G; Ritz E
Nephrol Dial Transplant; 1987; 2(1):22-5. PubMed ID: 3110692
[TBL] [Abstract][Full Text] [Related]
11. Haemodialysis-associated beta 2M amyloidosis: current controversies.
Stein G; Sperschneider H; Fünfstück R; Ritz E
Nephrol Dial Transplant; 1994; 9 Suppl 3():48-50. PubMed ID: 8072726
[TBL] [Abstract][Full Text] [Related]
12. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
[TBL] [Abstract][Full Text] [Related]
13. Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients.
Stein G; Schneider A; Thoss K; Ritz E; Schaefer K; Hüller M; Sperschneider H; Marzoll I
Nephrol Dial Transplant; 1991; 6 Suppl 3():57-61. PubMed ID: 1775270
[TBL] [Abstract][Full Text] [Related]
14. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
Floege J; Schäffer J; Koch KM; Shaldon S
Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
[TBL] [Abstract][Full Text] [Related]
15. Dialysis membranes inhibit synthesis and release of beta 2-microglobulin in lymphocyte culture.
Campistol JM; Molina R; Rodriguez R; Mirapeix E; Muñoz-Gomez J; Revert L
Nephron; 1991; 59(4):691-2. PubMed ID: 1809274
[No Abstract] [Full Text] [Related]
16. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
[TBL] [Abstract][Full Text] [Related]
17. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
[TBL] [Abstract][Full Text] [Related]
18. Involvement of peripheral blood monocytes in haemodialysis: in vivo induction of tumour necrosis factor alpha, interleukin 6 and beta 2-microglobulin.
Pertosa G; Marfella C; Tarantino EA; Di Cillo M; Manno C; Russo R; Schena FP
Nephrol Dial Transplant; 1991; 6 Suppl 2():18-23. PubMed ID: 1866063
[TBL] [Abstract][Full Text] [Related]
19. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
Gejyo F; Homma N; Arakawa M
Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting beta 2-microglobulin plasma concentration during hemodialysis.
Martin-Malo A; Mallol J; Castillo D; Barrio V; Burdiel LG; Perez R; Aljama P
Int J Artif Organs; 1989 Aug; 12(8):509-14. PubMed ID: 2681000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
